Target intelligence / Profile preview

Hepatic reticuloendothelial system

Molecular classification
Other
01

Overview

The "hepatic reticuloendothelial system" refers to the collection of specialized cells within the liver—primarily "Kupffer cells" (hepatic macrophages) and "liver sinusoidal endothelial cells (LSECs)"—that are responsible for clearing particulate matter, proteins, immune complexes, toxins, aged red blood cells, and pathogens from the blood[2][3][4][6]. These cells perform important immune functions, including phagocytosis and antigen presentation, and are essential for the liver's role as a blood filter[1][2][3][4][6]. While not a single molecule or receptor, the hepatic RES is a heterogeneous population of cells; its main roles are in host defense, immune regulation, and homeostasis of iron and other metabolites[1][2][3][4][5][6]. This system is critically involved in the clearance of intravenously administered particles, such as liposomes or nanoparticles, which can influence the pharmacokinetics and effectiveness of certain drugs and drug delivery systems[6]. Notes on correctness and classification: - The "hepatic reticuloendothelial system" is a tissue/cellular system, not a single molecular target, receptor, or protein. - It is not considered a therapeutic target in the conventional sense (e.g., receptor, enzyme)[2][3][5]. - Hepatic RES can influence drug delivery and efficacy by mediating uptake of nanoparticles, gene therapies, and certain macromolecules, thus representing a barrier rather than a targeted molecular entity[6]. - For molecular targeting, clarification or replacement by a specific component (for example, "Kupffer cell scavenger receptor") is needed.

Other names
Liver reticuloendothelial systemHepatic RESHepatic mononuclear phagocyte system
02

Biological functions

PhagocytosisImmune responseClearance of proteins, lipoproteins, and toxinsIron recyclingBreakdown of aged red blood cellsAntigen presentation
03

Disease associations

InfectionLiver diseaseInflammationBile duct obstructionSepsis
04

Safety considerations

Rapid clearance of drugs and nanoparticles from circulation, affecting efficacyPossible dose-limiting toxicity due to uptake and sequestration in liver

Beyond the preview

Go deeper on Hepatic reticuloendothelial system.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatic reticuloendothelial system.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call